XML 28 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Revenue $ 309,204 $ 298,542 $ 267,116
Costs and expenses:      
Partner Share and other third-party costs 150,578 155,507 141,273
Delivery costs 28,248 30,403 22,503
Sales and marketing expense 57,425 74,745 65,996
Research and development expense 51,352 54,435 38,104
General and administration expense 58,810 81,446 66,222
Acquisition, integration and divestiture (benefits) costs (6,313) (2,874) 24,372
Change in fair value of contingent consideration 1,246 (128,174) 1,374
Impairment of goodwill and intangible assets 70,518 453,288 0
Loss on divestiture 6,550 0 0
Depreciation and amortization expense 26,460 37,544 29,871
Total costs and expenses 444,874 756,320 389,715
Operating loss (135,670) (457,778) (122,599)
Other income (expense):      
Interest expense, net (2,336) (2,556) (12,563)
Other Nonoperating Income (Expense) 3,304 (6,376) (1,267)
Total other income (expense) 968 (8,932) (13,830)
Loss before income taxes (134,702) (466,710) (136,429)
Income tax benefit 0 1,446 7,864
Net Loss (134,702) (465,264) (128,565)
Net Loss attributable to common stockholders $ (134,702) $ (465,264) $ (128,565)
Net loss per share attributable to common stockholders, basic (in shares) $ (3.69) $ (13.92) $ (3.99)
Weighted-average common shares outstanding, basic (in shares) 36,488,000 33,419,000 32,202,000